Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for cebpa protein, human (compound)
Most Correlated Studies
- Chronic myelogenous leukemia cells engineered to express CEBPa-ER fusion protein
- Leukemia THP1 cells with CEBP siRNA knockdown treated with vitamin D
- Leukemia Kasumi-1 cells with conditional CEBPA-ER expression treated with estradiol
- Gene expression profiling of CEBPA double and single mutant and CEBPA WT AML
- HepG2 liver carcinoma cells in response to inhibition of DNA methylation and histone deacetylation
Most Relevant Literature
- T/myeloid MPAL with biallelic CEBPA mutations.
- CEBPA double mutations associated with ABO antigen weakness in hematologic diseases.
- Erythrophagocytosis by leukemic blasts with Auer body in acute myeloid leukemia with double mutant C…
- CEBPA bZIP in-frame mutations in acute myeloid leukemia: prognostic and therapeutic implications.
- Characteristic immunophenotype and gene co-mutational status orchestrate to optimize the prognosis o…
Most Relevant Clinical Trials
- Phase I Study of RNA Oligonucleotide, MTL-CEBPA, Atezolizumab and Bevacizumab in Patients With Advan…
- 3mg Liraglutide for Overweight or Obesity
- Lenalidomide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia
- Phase I Trial of AZD1775 and Belinostat in Treating Patients With Relapsed or Refractory Myeloid Mal…
- Oral Azacitidine (CC-486) Epigenetic Priming and Maintenance for Adult Acute Myeloid Leukemia (AML) …
